TrendingNews.today

S&P 500 5,142.30 ▲ +0.87%|NASDAQ 16,284.75 ▲ +1.12%|DOW 38,972.10 ▼ -0.23%|AAPL $192.45 ▲ +1.80%|TSLA $241.80 ▼ -2.10%|AMZN $178.92 ▲ +0.54%|GOOGL $141.20 ▲ +0.32%|MSFT $415.60 ▼ -0.15%|

S&P 500 5,142.30 ▲ +0.87%|NASDAQ 16,284.75 ▲ +1.12%|DOW 38,972.10 ▼ -0.23%|AAPL $192.45 ▲ +1.80%|TSLA $241.80 ▼ -2.10%|AMZN $178.92 ▲ +0.54%|GOOGL $141.20 ▲ +0.32%|MSFT $415.60 ▼ -0.15%|

BusinessUnited States1 sourcesNeutral

IDEAYA Biosciences Upcoming Investor Relations Events and Updated Darovasertib Topline Results Guidance from Phase 2/3 OptimUM-02 Trial

SOUTH SAN FRANCISCO, Calif., March 22, 2026 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation in upcoming investor relations events and provided...

CP

cision pr newswire

via Pr Newswire

March 22, 2026 | 2:00 PM UTCUpdated 3h ago

Share Read original

Read the full article at Pr Newswire →

IDEAYA Biosciences Upcoming Investor Relations Events and Updated Darovasertib Topline Results Guidance from Phase 2/3 OptimUM-02 Trial

Source Verification

Corroboration Score: 1

This story was independently reported by 1 sources. Click any source to read the original article.

Comments

0 comments

Be respectful and constructive.

Loading comments...

'I was fuming at boyfriend after checking pet cam while on a girl's trip'

Cory Booker: "We, the people, are the heroes this country needs"

Related Articles

Glitch Shuts Australia's Biggest Maker Of Vital Fertilizer Input For 2 Months At Worst Possible Time

Glitch Shuts Australia's Biggest Maker Of Vital Fertilizer Input For 2 Months At Worst Possible Time

Tyler Durden-3h ago-1 sources

Renewed Consolidation Likely For Thai Stock Market

Unknown-3h ago-2 sources

Soft Start Anticipated For Hong Kong Stock Market

Unknown-3h ago-2 sources